Faculty of Medicine news
Standards for authorizing first-time trials of drugs in humans are lax, and should be strengthened in several ways, McGill University researchers argue in a paper published today in Nature.
On Saturday, November 26 from 3am to 5pm, Facilities will be performing renovation work that will affect temperatures in the Schulich Library of Physical Sciences, Life Sciences and Engineering. The steam distribution system in the Macdonald-Stewart Library Building (Schulich Library) will be shut down in order to fix six leaks before the winter season sets in. As a result, library users may experience colder than normal temperatures. Spaces will be open for study but users should dress accordingly. We apologize for any inconvenience this may cause.
Following the approval of the GD16-09 Renaming Proposal submitted to the Board of Governors on October 6, 2016, Dr. C.
KalGene gears up to manufacture and test promising Alzheimer’s treatment with NRC, McGill and CIMTEC
KalGene Pharmaceuticals and the National Research Council of Canada (NRC) are proud to announce the signature of an agreement worth over $1M to develop, scale up, and transfer the technology needed to manufacture a promising novel Alzheimer’s treatment in Canada that the parties have been co- developing since 2015. The treatment, a biologic molecule made up of a peptide that fights Alzheimer’s and an antibody-based carrier molecule designed to shuttle the peptide into the brain, is a custom- engineered therapeutic developed at NRC.
Each year, the Department of Obstetrics & Gynecology at McGill organize a symposium to review new studies and practices in order to help practicing gynecologists, family physicians, residents, fellows and allied health professionals with interest in Women’s Health. (Website)
A receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer -- and schizophrenia drugs, which block the function of this receptor, slowed tumor growth and metastatic spread in mice, according to researchers at McGill University and the German Cancer Research Center.
TORONTO – September 1, 2016 – Ferring Canada, a subsidiary of Ferring Pharmaceuticals, is proud to announce a $2 million donation to McGill University in Montreal, Canada that will be used to create fellowships in health and health leadership, and to finance environmental research in the Canadian Arctic.
McGill University, in partnership with CBI-Concordia Physio Sport NDG, becomes FIFA Medical Centre of Excellence site
During a ceremony held August 29, 2016 at McGill University’s Faculty of Medicine, the School of Physical & Occupational Therapy (SPOT), in partnership with CBI-Concordia Physio Sport NDG, was officially recognized as a FIFA Medical Centre of Excellence. Joining the University of British Columbia as one of only two such sites accredited by FIFA in Canada, the primary focus of the Centre will be to educate the soccer community about different aspects of athletic performance from training principles, to nutrition and sport specific skills.
McGill Newsroom As a result of the overuse or misuse of antibiotics, antimicrobial resistant superbugs represent an extraordinary threat to global health. This threat is particularly great in India, the world’s largest consumer of antibiotics and the country facing the highest burden of tuberculosis (TB) in the world.
"To sleep - to sleep, perchance to dream”, these words made famous by William Shakespeare, in the play Hamlet are familiar to many of us. But did you know that sleep is just as important as diet and exercise for a healthy lifestyle?
McGill Newsroom 3D depth-sensing camera shown to measure walking difficulties A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patients. The Microsoft Kinect is a 3D depth-sensing camera used in interactive video activities such as tennis and dancing. It can be hooked up to an Xbox gaming console or a Windows computer.
McGill Newsroom Researchers find tools inaccurate and advise against routine screening in this age group
McGill Newsroom Extensive population-based studies on a popular group of drugs used to treat type 2 diabetes revealed no association with acute pancreatitis, but increased risk of bile duct and gallbladder disease